{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:09:55Z","timestamp":1790208595812,"version":"4.1.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamaoncol.2018.4951","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T16:40:37Z","timestamp":1543509637000},"page":"221","source":"Crossref","is-referenced-by-count":32,"title":["Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose"],"prefix":"10.1001","volume":"5","author":[{"given":"Kyle","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Pearlstein","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic H.","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra M.","family":"Mahbooba","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center Biostatistics Core, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center Biostatistics Core, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britni B.","family":"Motley","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Judy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Sheets","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit S.","family":"Kasibhatla","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather D.","family":"Pacholke","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette J.","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Zagar","sequence":"additional","affiliation":[{"name":"Northeastern Radiation Oncology, Glens Falls, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Marks","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhishamjit S.","family":"Chera","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"coi180091r1","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.1016\/j.ijrobp.2017.06.815","article-title":"Radiation utilization trends in the treatment of brain metastases from non-small cell lung cancer [abstract].","volume":"99","author":"Modh","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi180091r2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocn.2017.08.028","article-title":"National trends in radiotherapy for brain metastases at time of diagnosis of non-small cell lung cancer.","volume":"45","author":"Trifiletti","year":"2017","journal-title":"J Clin Neurosci"},{"key":"coi180091r3","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000441","article-title":"Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization: A National Cancer Database Study.","author":"Rydzewski","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"coi180091r4","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/cncr.v123.12","article-title":"Treatment trends for patients with brain metastases: does practice reflect the data?","volume":"123","author":"Sandler","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"coi180091r5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.5411","article-title":"The Diminishing Role of Whole-Brain Radiation Therapy in the Treatment of Brain Metastases.","volume":"3","author":"Li","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"coi180091r6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ijrobp.2008.12.013","article-title":"Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.","volume":"75","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi180091r7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.ijrobp.2011.09.025","article-title":"Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.","volume":"83","author":"Caissie","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi180091r8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1471-2407-12-283","article-title":"Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.","volume":"12","author":"Steinmann","year":"2012","journal-title":"BMC Cancer"},{"issue":"3","key":"coi180091r9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi180091r10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0360-3016(03)00361-4","article-title":"Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.","volume":"57","author":"Lin","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180091r11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijrobp.2006.09.021","article-title":"The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.","volume":"67","author":"Li","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi180091r12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.","volume":"62","author":"Blanco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180091r13","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function.","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi180091r14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"coi180091r15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2010.12.013","article-title":"Parotid gland as a risk organ in whole brain radiotherapy.","volume":"98","author":"Noh","year":"2011","journal-title":"Radiother Oncol"},{"issue":"9","key":"coi180091r16","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/j.clon.2012.07.003","article-title":"Technique of whole brain radiotherapy: conformity index and parotid glands.","volume":"24","author":"Fiorentino","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"coi180091r17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3857\/roj.2013.31.1.12","article-title":"Parotid gland sparing effect by computed tomography-based modified lower field margin in whole brain radiotherapy.","volume":"31","author":"Cho","year":"2013","journal-title":"Radiat Oncol J"},{"issue":"3","key":"coi180091r18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11547-014-0436-6","article-title":"Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing.","volume":"120","author":"Trignani","year":"2015","journal-title":"Radiol Med"},{"issue":"2","key":"coi180091r19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.meddos.2017.02.006","article-title":"Whole-brain Irradiation Field Design: A Comparison of Parotid Dose.","volume":"42","author":"Wu","year":"2017","journal-title":"Med Dosim"},{"issue":"5","key":"coi180091r20","first-page":"e1217","article-title":"Differences in Parotid Dosimetry and Expected Normal Tissue Complication Probabilities in Whole Brain Radiation Plans Covering C1 Versus C2.","volume":"9","author":"Orton","year":"2017","journal-title":"Cureus"},{"issue":"2","key":"coi180091r21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijrobp.2006.05.002","article-title":"Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.","volume":"66","author":"Meirovitz","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180091r22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","article-title":"Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.","volume":"17","author":"Bjordal","year":"1999","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi180091r23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"issue":"2","key":"coi180091r24","first-page":"114","article-title":"Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: results of the WFU CCOP research base protocol 91105.","volume":"5","author":"Naughton","year":"2018","journal-title":"Neurooncol Pract"},{"issue":"34","key":"coi180091r25","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi180091r26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"4","key":"coi180091r27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Acute parotitis and hyperamylasemia following whole-brain radiation therapy.","volume":"7","author":"Cairncross","year":"1980","journal-title":"Ann Neurol"},{"issue":"8","key":"coi180091r28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial.","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"coi180091r29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-8140(01)00427-3","article-title":"Parotid and submandibular\/sublingual salivary flow during high dose radiotherapy.","volume":"61","author":"Burlage","year":"2001","journal-title":"Radiother Oncol"},{"key":"coi180091r30","unstructured":"Mehta M. RTOG 0933 protocol information. A phase II trial of hippocampal avoidance during whole brain radiotherapy for brain metastases\u2013RTOG CCOP Study. https:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0933. Version date December 5, 2011. Accessed March 13, 2016."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/2\/221\/17295282\/jamaoncology_wang_2018_oi_180091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:35:44Z","timestamp":1550162144000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.4951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.4951","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}